The focus of my laboratory is to explore the underlying mechanisms and potential of neuromodulation for cognitive dysfunction and psychiatric disorders, such as Alzheimer’s disease, Parkinson’s disease, epilepsy, depression, obsessive compulsive disorder and schizophrenia. Specifically, we utilize multiple depth electrode local field potential recordings and functional ultrasound imaging to evaluate simultaneous electrophysiology, cerebral blood flow and functional connectivity in these disorders. Using these tools, our goal is to better understand the underlying pathophysiology and optimize our neuromodulation strategies. Our aim is to translate our preclinical findings into clinically relevant neuromodulation treatments. My clinical research is focused on evaluating potential new indications and targets for neuromodulation, such as deep brain stimulation (DBS), spinal cord stimulation and focused ultrasound.
The focus of my laboratory is to explore the underlying mechanisms and potential of neuromodulation for cognitive dysfunction and psychiatric disorders, such as Alzheimer’s disease, Parkinson’s disease, epilepsy, depression, obsessive compulsive disorder and schizophrenia. Specifically, we utilize multiple depth electrode local field potential recordings and functional ultrasound imaging to evaluate simultaneous electrophysiology, cerebral blood flow and functional connectivity in these disorders. Using these tools, our goal is to better understand the underlying pathophysiology and optimize our neuromodulation strategies. Our aim is to translate our preclinical findings into clinically relevant neuromodulation treatments. My clinical research is focused on evaluating potential new indications and targets for neuromodulation, such as deep brain stimulation (DBS), spinal cord stimulation and focused ultrasound.
